<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen HY</submitter><funding>NIBIB NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>2609-2620</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9794017</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>88(6)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To develop techniques and establish a workflow using hyperpolarized carbon-13 (&lt;sup>13&lt;/sup> C) MRI and the pyruvate-to-lactate conversion rate (k&lt;sub>PL&lt;/sub> ) biomarker to guide MR-transrectal ultrasound fusion prostate biopsies.&lt;h4>Methods&lt;/h4>The integrated multiparametric MRI (mpMRI) exam consisted of a 1-min hyperpolarized &lt;sup>13&lt;/sup> C-pyruvate EPI acquisition added to a conventional prostate mpMRI exam. Maps of k&lt;sub>PL&lt;/sub> values were calculated, uploaded to a picture archiving and communication system and targeting platform, and displayed as color overlays on T&lt;sub>2&lt;/sub> -weighted anatomic images. Abdominal radiologists identified &lt;sup>13&lt;/sup> C research biopsy targets based on the general recommendation of focal lesions with k&lt;sub>PL&lt;/sub>  >0.02(s&lt;sup>-1</pubmed_abstract><journal>Magnetic resonance in medicine</journal><pubmed_title>Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized &lt;sup>13&lt;/sup> C pyruvate metabolic imaging: A technical development study.</pubmed_title><pmcid>PMC9794017</pmcid><funding_grant_id>U01 EB026412</funding_grant_id><funding_grant_id>P41 EB013598</funding_grant_id><funding_grant_id>R01 CA238379</funding_grant_id><funding_grant_id>U01 CA232320</funding_grant_id><pubmed_authors>Gebrezgiabhier D</pubmed_authors><pubmed_authors>Gordon JW</pubmed_authors><pubmed_authors>Aggarwal R</pubmed_authors><pubmed_authors>Cooperberg MR</pubmed_authors><pubmed_authors>Kurhanewicz J</pubmed_authors><pubmed_authors>Wang ZJ</pubmed_authors><pubmed_authors>Larson PEZ</pubmed_authors><pubmed_authors>Shinohara K</pubmed_authors><pubmed_authors>Nguyen HG</pubmed_authors><pubmed_authors>Vigneron DB</pubmed_authors><pubmed_authors>Westphalen AC</pubmed_authors><pubmed_authors>Carvajal L</pubmed_authors><pubmed_authors>Chen HY</pubmed_authors><pubmed_authors>Bok RA</pubmed_authors><pubmed_authors>Ohliger MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized &lt;sup>13&lt;/sup> C pyruvate metabolic imaging: A technical development study.</name><description>&lt;h4>Purpose&lt;/h4>To develop techniques and establish a workflow using hyperpolarized carbon-13 (&lt;sup>13&lt;/sup> C) MRI and the pyruvate-to-lactate conversion rate (k&lt;sub>PL&lt;/sub> ) biomarker to guide MR-transrectal ultrasound fusion prostate biopsies.&lt;h4>Methods&lt;/h4>The integrated multiparametric MRI (mpMRI) exam consisted of a 1-min hyperpolarized &lt;sup>13&lt;/sup> C-pyruvate EPI acquisition added to a conventional prostate mpMRI exam. Maps of k&lt;sub>PL&lt;/sub> values were calculated, uploaded to a picture archiving and communication system and targeting platform, and displayed as color overlays on T&lt;sub>2&lt;/sub> -weighted anatomic images. Abdominal radiologists identified &lt;sup>13&lt;/sup> C research biopsy targets based on the general recommendation of focal lesions with k&lt;sub>PL&lt;/sub>  >0.02(s&lt;sup>-1</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-28T01:32:11.688Z</modification><creation>2025-02-19T04:23:48.639Z</creation></dates><accession>S-EPMC9794017</accession><cross_references><pubmed>35975978</pubmed><doi>10.1002/mrm.29399</doi></cross_references></HashMap>